• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDINAL HEALTH SANTA CLARA MYNXGRIP; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDINAL HEALTH SANTA CLARA MYNXGRIP; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Catalog Number MX6721
Device Problems Decrease in Pressure (1490); Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/23/2023
Event Type  malfunction  
Manufacturer Narrative
This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.
 
Event Description
As reported, the balloon of a 6/7f mynx grip vascular closure device (vcd) ruptured during patient use.Hemostasis was achieved by manual compression for less than 30 minutes.There was no reported patient injury.The device was stored and prepared in accordance with the instructions for use.The device was used in an interventional procedure using a retrograde approach.The deployer was mynx certified.The vcd was used with a 6f non-cordis sheath.The femoral artery¿s suitability was verified on angiography, including the insertion angle (30-45 degrees) of the vascular sheath introducer.The vessel diameter was verified to be greater than or equal to 5mm in diameter.There was little vessel tortuosity.There was no presence of peripheral vascular disease or calcium in the vicinity of the puncture site.There was no prior pta, stent, or vascular graft in the common femoral artery or vein.There was no visible damage to the distal end of the sheath after removal.The device will be returned for evaluation.
 
Manufacturer Narrative
After further review of additional information received the following sections have been updated accordingly: d2, g1, g3, g6, h1, h2, h3 and h6.The balloon of a 6/7f mynx grip vascular closure device (vcd) ruptured during patient use.Hemostasis was achieved by manual compression for less than 30 minutes.There was no reported patient injury.The device was stored and prepared in accordance with the instructions for use.The device was used in an interventional procedure using a retrograde approach.The deployer was mynx certified.The vcd was used with a 6f non-cordis sheath.The femoral artery¿s suitability was verified on angiography, including the insertion angle (30-45 degrees) of the vascular sheath introducer.The vessel diameter was verified to be greater than or equal to 5mm in diameter.There was little vessel tortuosity.There was no presence of peripheral vascular disease or calcium in the vicinity of the puncture site.There was no prior pta, stent, or vascular graft in the common femoral artery or vein.There was no visible damage to the distal end of the sheath after removal.The product was returned for analysis.A non-sterile mynxgrip vascular closure device 6f/7f was returned for investigation inside a clear plastic bag.Per visual analysis the shuttle was disengaged to the black handle.The syringe was received attached with the device and the stopcock was found open.The sealant and advancer tube remained in the manufacturing position.The procedure sheath was not returned.In addition, the balloon was received fully deflated.Per functional analysis an inflation/deflation test was performed which revealed a leak in the balloon of the returned device.Per microscopic analysis a longitudinal tear in the balloon was revealed.The reported ¿balloon loss of pressure¿ was confirmed during analysis of the returned device.The exact cause of the reported event could not be conclusively determined.This type of tear is typically observed when the balloon comes into contact with calcification and/or other procedural devices (such as a damaged procedural sheath, stent or vascular graft).Vessel characteristics may have contributed to the reported event.According to the instructions for use, which is not intended as a mitigation of risk, users are instructed not to use the device if the balloon does not maintain pressure.Neither the event description nor the product analysis suggests that the reported event could be related to the manufacturing process of the unit.Therefore, no corrective actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYNXGRIP
Type of Device
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
CARDINAL HEALTH SANTA CLARA
5452 betsy ross drive
santa clara CA 95054
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
5452 betsy ross drive
santa clara, CA 95054
7863138372
MDR Report Key18169821
MDR Text Key328535050
Report Number3004939290-2023-03497
Device Sequence Number1
Product Code MGB
UDI-Device Identifier10862028000410
UDI-Public10862028000410
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/20/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMX6721
Device Lot NumberF2234602
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/07/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/12/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/12/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6F TERUMO SHEATH
-
-